Compound comparison · Research use only

Ipamorelin vs Sermorelin

Ipamorelin is a pentapeptide GH secretagogue / GHSR-1a agonist. Sermorelin is a growth hormone-releasing hormone (GHRH) analog; N-terminal 29-amino-acid fragment of human GHRH. They are different materials with different identities and different research literatures; the table below sets the two identities side by side, the sections after it summarise what each is studied for, and the certificate rows show how each has tested.

Identity

Ipamorelin and Sermorelin side by side

FieldIpamorelinSermorelin
Catalogue nameIpamorelinSermorelin
TypeSingle peptideSingle peptide
ClassPentapeptide GH secretagogue / GHSR-1a agonistGrowth hormone-releasing hormone (GHRH) analog; N-terminal 29-amino-acid fragment of human GHRH
ComponentsSingle compoundSingle compound
Molecular formulaC38H49N9O5C149H246N44O42S
Molecular weight711.85 Da3357.93 Da
Sequence length5 residues29 residues
CAS or identifier170851-70-486168-78-7
Form suppliedLyophilized powderLyophilized powder
Sizes10mg10mg
Price from$70$85
Documented HPLC results4 (99.51 to 99.98%)5 (99.03 to 99.84%)
Testing laboratoriesFreedom DiagnosticsAccurate Test Labs, Freedom Diagnostics

Identity fields come from the catalogue entry for each compound. Certificate counts are documented third-party HPLC results with a published certificate; image-only documents are excluded from the counts.

Mechanisms

What the research literature describes

Ipamorelin

  • Ghrelin Receptor Activation GHSR-1a Agonist
  • No Cortisol or Prolactin Elevation Selectivity
  • Physiologic GH Secretion Pattern Pulsatile GH

Sermorelin

  • GHRH Receptor Agonism GHRH-R
  • Downstream IGF-1 Signaling GH → IGF-1
  • Preserved Physiologic Rhythm Feedback
  • Upstream, Not Exogenous Upstream
  • Short Plasma Half-Life Half-Life
  • GHRH(1-29) Active Fragment Sequence
Research focus

What each is studied for

Ipamorelin

  • Selective GH Secretagogue Endocrinology
  • GH Secretion & Sleep Sleep Research
  • Bone Growth Models Musculoskeletal
  • Synergy with GHRH Analogs Combination Research

Sermorelin

  • Growth Hormone Axis Endocrine
  • Body Composition Models Body Composition
  • Slow-Wave Sleep Sleep Architecture
  • Somatopause Aging Research

Headings name the mechanisms and research applications described for each compound; the full text of each sits on the compound monograph linked below. They summarise findings reported in preclinical models. They describe what has been studied, not outcomes in people or animals outside the laboratory.

Go deeper

Catalogue, monographs and certificates

What is the difference between Ipamorelin and Sermorelin?

Ipamorelin is a pentapeptide GH secretagogue / GHSR-1a agonist; Sermorelin is a growth hormone-releasing hormone (GHRH) analog; N-terminal 29-amino-acid fragment of human GHRH. Ipamorelin has 5 residues and Sermorelin has 29. Their molecular identities, the models they have been studied in and their certificate records are all listed on this page.

Are Ipamorelin and Sermorelin sold together?

No. Eon Peptides lists them as separate catalogue items, each with its own sizes and its own certificates.

How has each tested?

Ipamorelin: 4 documented third-party HPLC results from 99.51% to 99.98%. Sermorelin: 5 documented results from 99.03% to 99.84%. Every certificate is published and linked from each compound's lab results page.

Which one should a research project use?

That depends on the pathway and model under study, which is a scientific question this page does not answer. What it does is put the identities, the described mechanisms and the analytical records side by side so the choice can be made on documented facts. Both materials are for laboratory research use only.

For research use only. Not for human or veterinary use. Nothing on this page describes or recommends use in people or animals.